Eli Lilly Trial Finds Alzheimer’s Drug Can Slow Progress of Disease Donanemab is not a cure and comes with significant side effects, but patients had longer periods of independent living while on the drug. https://bit.ly/3jvLQpp https://nyti.ms/3eyQv5F

Donanemab is not a cure and comes with significant side effects, but patients had longer periods of independent living while on the drug.

from NYT > Top Stories https://nyti.ms/3oXkkHq
via IFTTT